Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Lite Strategy, Inc.MEIP · Entity 7396 | Director | July 01, 2021 | July 06, 2021 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Lite Strategy, Inc.
Report date July 01, 2021 · Filed July 06, 2021
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.95 · Expires 2031-07-01 | Direct | 50,000 |
Reported balance
After 2021-07-01 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2021-07-01 · Grant · Acquired 50,000 · Balance 50,000 F1: The options will vest in equal monthly installments over twelve months. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $6.47 · Expires 2024-12-03 | Direct | 12,667 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · Balance 12,667 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.57 · Expires 2025-07-28 | Direct | 20,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 20,000 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.36 · Expires 2026-07-29 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 40,000 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.83 · Expires 2027-07-06 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · Balance 40,000 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.28 · Expires 2028-07-12 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · Balance 40,000 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $2.52 · Expires 2029-07-01 | Direct | 40,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 40,000 F2: All of such options are presently exercisable. |
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.49 · Expires 2030-07-02 | Direct | 50,000 |
Reported balance
Holding disclosure · report date 2021-07-01 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 50,000 F2: All of such options are presently exercisable. |
Filing footnotes · ownership attribution and instrument terms
F1: The options will vest in equal monthly installments over twelve months.
F2: All of such options are presently exercisable.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 01, 2021 Filed Jul 6, 2021 22:55 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-045651 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2031-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 02, 2020 Filed Jul 7, 2020 17:05 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $3.49 | $0.00 |
DisclosureSEC source: 0000899243-20-018610 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2030-07-02 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 01, 2019 Filed Jul 3, 2019 19:31 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $2.52 | $0.00 |
DisclosureSEC source: 0001209191-19-040976 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2029-07-01 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 12, 2018 Filed Jul 16, 2018 21:25 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantStock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $4.28 | $0.00 |
DisclosureSEC source: 0001209191-18-042665 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2028-07-12 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
| July 06, 2017 Filed Jul 10, 2017 18:32 UTC | Lite Strategy, Inc. MEIP · Entity 7396 | GrantOption to purchase shares of common stock · Derivative | 40,000 | $0.00 Strike: $2.83 | $0.00 |
DisclosureSEC source: 0001209191-17-044527 · doc4.xml · derivative · entry 1 Clemens Kevan · CIK 0001316737 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,667 Underlying: Common Stock par value $0.00000002 · 40,000 shares Expires 2027-07-06 F1 · derivative.exercise_date: The options will vest in equal monthly installments over twelve months. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.